Clinical survey of 1380 syphilis patients in Leipzig from 1983 to 1991. NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Clinical survey of 1380 syphilis patients in Leipzig from 1983 to 1991.

Int Conf AIDS. 1993 Jun 6-11;9(1):103 (abstract no. WS-C22-4). Unique Identifier : AIDSLINE MED/93333238
Haustein UF; Pfeil B; Dept. of Dermatology, University of Leipzig, Germany.

Abstract: 1380 patients with syphilis were observed at our Department in West Saxonia of Germany, with 1.4 mill. population from 1983 to 1991. The incidence of syphilis has increased gradually from 1983 to 1989, but decreased between 1990 to 1991. The number of recent infectious syphilis cases was almost twice as high as latent syphilis cases (63%:37%). As a source of infection 44% were casual contacts, 30% were stable partners, 6% were homosexuals and 4% were prostitutes. Among primary syphilis cases, multiple cancers were seen in 16%. Among secondary syphilis cases macular and maculopapular exanthema were the commonest features (51%), followed by palmoplantar syphilis (5%), condylomata lata (5%), angina specifica (3%), and papular exanthema (3%). However, in 31% of cases multiple skin features were observed. Secondary syphilis with persistent chancres were seen in 12%. In general, the number of atypical syphilis cases is gradually increasing. 5% of the patients suffered from the second until the fifth reinfection in their lives and again 5% of syphilis cases were pregnant. Only two patients had AIDS, 10% suffered from gonorrhoea, 10% from trichomoniasis, 12% from chlamydial infection, 4% from genital warts, and 8% from herpes simplex genitalis, at the same time. Proposals for prevention, combat and control of STD were made.
Keywords: *Syphilis/PHYSIOPATHOLOGYKWDsyphilis/physiopathology
931130
M93B5810

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .